Extracellular nucleotides regulate CCL20 release from human primary airway epithelial cells, monocytes and monocyte-derived dendritic cells

Journal of Cellular Physiology

Volumn 211, Issue 3, 2007, Pages 716-727

  Marcet, Brice ^a,c   Horckmans, Michael ^a   Libert, Frédérick ^a   Hassid, Sergio ^b   Boeynaems, Jean Marie ^a,b   Communi, Didier ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c NONE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHEMOKINE; CHEMOKINE CCL20; DIQUAFOSOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INS 48823; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NUCLEOTIDE; PROTEIN INHIBITOR; PURINE P2Y2 RECEPTOR; PURINE P2Y6 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DNA MICROARRAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; ION TRANSPORT; LEUKOCYTE MIGRATION; MONOCYTE; MUCOCILIARY CLEARANCE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHEMOKINES, CC; CHEMOTAXIS; DENDRITIC CELLS; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; EXTRACELLULAR SPACE; GENE EXPRESSION; HUMANS; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MACROPHAGE INFLAMMATORY PROTEINS; MONOCYTES; NASAL MUCOSA; NEUTROPHILS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, PURINERGIC P2; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; URIDINE TRIPHOSPHATE;

EID: 34247595353     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20979     Document Type: Article

References (73)

1. 14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 24:52-55.
2. Balough K, McCubbin M, Weinberger M, Smits W, Ahrens R, Pick R. 1995. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol 20:63-70.
3. Bals R, Hiemstra PS. 2004. Innate immunity in the lung: How epithelial cells fight against respiratory pathogens. Eur Respir J 23:327-333.
4. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. 2000. Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811.
5. Bennett WD, Olivier KN, Zeman KL, Hohneker KW, Boucher RC, Knowles MR. 1996. Effect of uridine 5′-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis. Am J Respir Crit Care Med 153:1796-1801.
6. Chunn JL, Mohsenin A, Young HW, Lee CG, Elias JA, Kellems RE, Blackburn MR. 2006. Partially adenosine deaminase-deficient mice develop pulmonary fibrosis in association with adenosine elevations. Am J Physiol Lung Cell Mol Physiol 290:L579-L587.
7. Clarke LL, Grubb BR, Yankaskas JR, Cotton CU, McKenzie A, Boucher RC 1994. Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr(-/-) mice. Proc Natl Acad Sci USA 91:479-483.
8. Communi D, Parmentier M, Boeynaems JM. 1996. Cloning, functional expression and tissue distribution of the human P2Y6 receptor. Biochem Biophys Res Commun 222:303-308.
9. Communi D, Robaye B, Boeynaems JM. 1999. Pharmacological characterization of the human P2Y11 receptor. Br J Pharmacol 128:1199-1206.
10. Davis PB, Drumm M, Konstan MW. 1996. Cystic fibrosis. Am J Respir Crit Care Med 154:1229-1256.
11. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Ait-Yahia S, Briere F, Zlotnik A, Lebecque S, Caux C. 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188:373-386.
12. el-Moatassim C, Dornand J, Mani JC. 1992. Extracellular ATP and cell signalling. Biochim Biophys Acta 1134:31-45.
13. Homolya L, Steinberg TH, Boucher RC. 2000. Cell to cell communication in response to mechanical stress via bilateral release of ATP and UTP in polarized epithelia. J Cell Biol 150:1349-1360.
14. Hoover DM, Boulegue C, Yang D, Oppenheim JJ, Tucker K, Lu W, Lubkowski J. 2002. The structure of human macrophage inflammatory protein-3alpha/CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins. J Biol Chem 277:37647-37654.
15. Horckmans M, Marcet B, Marteau F, Bulte F, Maho A, Parmentier M, Boeynaems J-M, Communi D. 2006. Extracellular adenine nucleotides inhibit the release of major monocyte recruiters by human monocyte-derived dendritic cells. FEBS Lett 580:747-754.
16. Idzko M, Panther E, Sorichter S, Herouy Y, Berod L, Geissler M, Mockenhaupt M, Elsner P, Girolomoni G, Norgauer J. 2004. Characterization of the biological activities of uridine diphosphate in human dendritic cells: Influence on chemotaxis and CXCL8 release. J Cell Physiol 201:286-293.
17. Jayaraman S, Song Y, Vetrivel L, Shankar L, Verkman AS. 2001. Noninvasive in vivo fluorescence measurement of airway-surface liquid depth, salt concentration, and pH. J Clin Invest 107:317-324.
18. Kao CY, Huang F, Chen Y, Thai P, Wachi S, Kim C, Tam L, Wu R. 2005. Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK/NF-kappaB-dependent signaling pathway. J Immunol 175:6676-6685.
19. Kellerman D, Evans R, Mathews D, Shaffer C. 2002. Inhaled P2Y2 receptor agonists as a treatment for patients with cystic fibrosis lung disease. Adv Drug Dev Rev 54:1463-1474.
20. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. 1995. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151:1075-1082.
21. Knowles MR, Clarke LL, Boucher RC. 1991. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N Engl J Med 325:533-538.
22. Korcok J, Raimundo LN, Du X, Sims SM, Dixon SJ. 2005. P2Y6 nucleotide receptors activate NF-kappaB and increase survival of osteoclasts. J Biol Chem 280:16909-16915.
23. la Sala A, Ferrari D, Corinti S, Cavani A, Di Virgilio F, Girolomoni G. 2001. Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. J Immunol 166:1611-1617.
24. la Sala A, Sebastiani S, Ferrari D, Di Virgilio F, Idzko M, Norgauer J, Girolomoni G. 2002. Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes. Blood 99:1715-1722.
25. Lambrecht BN, Hammad H. 2003. The other cells in asthma: Dendritic cell and epithelial cell croostalk. Curr Opin Pulm Med 9:34-41.
26. Lazarowski ER, Boucher RC. 2001. UTP as an extracellular signaling molecule. News Physiol Sci 16:1-5.
27. Lazarowski ER, Tarran R, Grubb BR, van Heusden CA, Okada S, Boucher RC. 2004. Nucleotide release provides a mechanism for airway surface liquid homeostasis. J Biol Chem 279:36855-36864.
28. Leipziger J. 2003. Control of epithelial transport via luminal P2 receptors. Am J Physiol Renal Physiol 284:F419-F432.
29. Lugering A, Kucharzik T, Soler D, Picarella D, Hudson JT III, Williams IR. 2003. Lymphoid precursors in intestinal cryptopatches express CCR6 and undergo dysregulated development in the absence of CCR6. J Immunol 171:2208-2215.
30. Lukacs NW, Prosser DM, Wiekowski M, Lira SA, Cook DN. 2001. Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation. J Exp Med 194:551-555.
31. Marcet B, Boeynaems J-M. 2006. Relationships between cystic fibrosis transmembrane conductance regulator (CFTR), extracellular nucleotides and cystic fibrosis. Pharmacol Ther 112:719-732.
32. Marcet B, Chappe V, Delmas P, Gola M, Verrier B. 2003. Negative regulation of CFTR activity by extracellular ATP involves P2Y2 receptors in CFTR-expressing CHO cells. J Membrane Biol 194:21-32.
33. Marcet B, Chappe V, Delmas P, Verrier B. 2004. Pharmacological and signaling properties of endogenous P2Y1 receptors in cystic fibrosis transmembrane conductance regulator-expressing Chinese hamster ovary cells. J Pharmacol Exp Ther 309:533-539.
34. Marteau F, Gonzalez NS, Communi D, Goldman M, Boeynaems J-M, Communi D. 2005. Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells. Blood 106:3860-3866.
35. Mason SJ, Paradiso AM, Boucher RC. 1991. Regulation of transepithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epithelium. Br J Pharmacol 103:1649-1656.
36. Merten MD, Kammouni W, Renaud W, Birg F, Mattei MG, Figarella C. 1996. A transformed human tracheal gland cell line, MM-39, that retains serous secretory functions. Am J Respir Cell Mol Biol 15:520-528.
37. Meshki J, Tuluc F, Bredetean O, Ding Z, Kunapuli SP. 2004. Molecular mechanism of nucleotide-induced primary granule release in human neutrophils: Role for the P2Y2 receptor. Am J Physiol Cell Physiol 286:C264-C271.
38. Morse DM, Smullen JL, Davis CW. 2001. Differential effects of UTP, ATP, and adenosine on ciliary activity of human nasal epithelial cells. Am J Physiol Cell Physiol 280:C1485-C1497.
39. Mul FP, Zuurbier AE, Janssen H, Calafat J, van Wetering S, Hiemstra PS, Roos D, Hordijk PL 2000. Sequential migration of neutrophils across monolayers of endothelial and epithelial cells. J Leukoc Biol 68:529-537.
40. Natarajan K, Singh S, Burke TR, Jr., Grunberger D, Aggarwal BB. 1996. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci USA 93:9090-9095.
41. Noone PG, Bennett WD, Regnis JA, Zeman KL, Carson JL, King M, Boucher RC, Knowles MR. 1999. Effect of aerosolized uridine-5′-triphosphate on airway clearance with cough in patients with primary ciliary dyskinesia. Am J Respir Crit Care Med 160:144-149.
42. Noone PG, Hamblett N, Accurso F, Aitken ML, Boyle M, Dovey M, Gibson R, Johnson C, Kellerman D, Konstan MW, Milgram L, Mundahl J, Retsch-Bogort G, Rodman D, Williams-Warren J, Wilmott RW, Zeitlin P, Ramsey B. Cystic Fibrosis Therapeutics Development Research Group. 2001. Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: Results of a phase I multi-center study. Pediatr Pulmonol 32:122-128.
43. Oei E, Kalb T, Beuria P, Allez M, Nakazawa A, Azuma M, Timony M, Stuart Z, Chen H, Sperber K. 2004. Accessory cell function of airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 287:L318-L331.
44. Olivier KN, Bennett WD, Hohneker KW, Zeman KL, Edwards LJ, Boucher RC, Knowles MR. 1996. Acute safety and effects on mucociliary clearance of aerosolized undine 5′-triphosphate amiloride in normal human adults. Am J Respir Crit Care Med 154:217-223.
45. Palmer ML, Lee SY, Carlson D, Fahrenkrug S, O'Grady SM. 2006. Stable knockdown of CFTR establishes a role for the channel in P2Y receptor-stimulated anion secretion. J Cell Physiol 206:759-770.
46. Paradiso AM, Ribeiro CMP, Boucher RC. 2001. Polarized signaling via purinoceptors in normal and cystic fibrosis airway epithelia. J Gen Physiol 117:53-67.
47. Parr CE, Sullivan DM, Paradiso AM, Lazarowski ER, Burch LH, Olsen JC, Erb L, Weisman GA, Boucher RC, Turner JT. 1994. Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sci USA 91:3275-3279.
48. Pendergast W, Yerxa BR, Douglass JGIII, Shaver SR, Dougherty RW, Redick CC, Sims IF, Rideout JL. 2001. Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5′-polyphosphates. Bioorg Med Chem Lett 11:157-160.
49. Picher M, Burch LH, Boucher RC. 2004. Metabolism of P2 receptor agonists in human airways: Implications for mucociliary clearance and cystic fibrosis. J Biol Chem 279:20234-20241.
50. Pirotton S, Verjans B, Boeynaems J-M, Erneux C. 1991. Metabolism of inositol phosphates in ATP-stimulated vascular endothelial cells. Biochem J 277:103-110.
51. Ralevic V, Burnstock G. 1998. Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
52. Reibman J, Hsu Y, Chen LC, Bleck B, Gordon T. 2003. Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter. Am J Respir Cell Mol Biol 28:648-654.
53. Ribeiro CM, Paradiso AM, Schwab U, Perez-Vilar J, Jones L, O'neal W, Boucher RC. 2005. Chronic airway infection/inflammation induces a Ca2dependent hyperinflammatory response in human cystic fibrosis airway epithelia. J Biol Chem 280:17798-17806.
54. Rimoldi M, Chieppa M, Larghi P, Vulcano M, Allavena P, Rescigno M. 2005. Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different. Blood 106:2818-2826.
55. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G. 1994. Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83-93.
56. Sabater JR, Mao YM, Shaffer C, James MK, O'Riordan TG, Abraham WM. 1999. Aerosolization of P2Y(2)-receptor agonists enhances mucociliary clearance in sheep. J Appl Physiol 87:2191-2196.
57. Santiago-Perez LI, Flores RV, Santos-Berrios C, Chorna NE, Krugh B, Garrad RC, Erb L. Weisman GA, Gonzalez FA. 2001. P2Y(2) nucleotide receptor signaling in human monocytic cells: Activation, desensitization and coupling to mitogen-activated protein kinases. J Cell Physiol 187:196-208.
58. Scapini P, Crepaldi L, Pinardi C, Calzetti F, Cassatella MA. 2002. CCL20/macrophage inflammatory protein-3alpha production in LPS-stimulated neutrophils is enhanced by the chemoattractant formyl-methionyl-leucyl- phenylalanine and IFN-gamma through independent mechanisms. Eur J Immunol 32:3515-3524.
59. Schnurr M, Then F, Galambos P, Scholz C, Siegmund B, Endres S, Eigler A. 2000. Extracellular ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells. J Immunol 165:4704-4709.
60. Schutyser E, Struyf S, Van Damme J. 2003. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 14:409-426.
61. Singh PK, Jia HP, Wiles K, Hesselberth J, Liu L, Conway BA, Greenberg EP, Valore EV, Welsh MJ, Ganz T, Tack BF, McCray PB, Jr. 1998. Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci USA 95:14961-14966.
62. Starner TD, Barker CK, Jia HP, Kang Y, McCray PB Jr. 2003. CCL20 is an inducible product of human airway epithelia with innate immune properties. Am J Respir Cell Mol Biol 29:627-633.
63. Stick SM, Holt PG. 2003. The airway epithelium as immune modulator: The LARC ascending. Am J Respir Cell Mol Biol 28:641-644.
64. Tabary O, Zahm JM, Hinnrasky J, Couetil JP, Cornillet P, Guenounou M, Gaillard D, Puchelle E, Jacquot J. 1998. Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am J Pathol 153:921-930.
65. Tarran R, Button B, Boucher RC. 2006. Regulation of normal and cystic fibrosis airway surface liquid volume by phasic shear stress. Annu Rev Physiol 68:543-561.
66. Thorley AJ, Goldstraw P, Young A, Tetley TD. 2005. Primary human alveolar type Il epithelial cell CCL20 (macrophage inflammatory protein-3alpha)-induced dendritic cell migration. Am J Respir Cell Mol Biol 32:262-267.
67. Warny M, Aboudola S, Robson SC, Sevigny J, Communi D, Soltoff SP, Kelly CP. 2001. P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J Biol Chem 276:26051-26056.
68. Wilkin F, Duhant X, Bruyns C, Suarez-Huerta N, Boeynaems J-M, Robaye B. 2001. The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J Immunol 166:7172-7177.
69. Wilkin F, Stordeur P, Goldman M, Boeynaems J-M, Robaye B. 2002. Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: Dual effect on IL-12 and stimulation of IL-10. Eur J Immunol 32:2409-2417.
70. Wu R, Yankaskas J, Cheng E, Knowles MR, Boucher R. 1985. Growth and differentiation of human nasal epithelial cells in culture. Serum-free, hormone-supplemented medium and proteoglycan synthesis. Am Rev Respir Dis 132:311-320.
71. Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, Oppenheim JJ. 2003. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 74:448-455.
72. Yang L, Cranson D, Trinkaus-Randall V. 2004. Cellular injury induces activation of MAPK via P2Y receptors. J Cell Biochem 91:938-950.
73. Yerxa BR, Sabater JR, Davis CW, Stutts MJ, Lang-Furr M, Picher M, Jones AC, Cowlen M, Dougherty R, Boyer J, Abraham WM, Boucher RC. 2002. Pharmacology of INS37217 [P(I)-(uridine 5′)-P(4)-(2′-deoxycytidine 5′)tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis. J Pharmacol Exp Ther 302:871-880.